Is high triglycerides a sign of metabolic syndrome or fatty liver?

High triglycerides (above 150 mg/dL) are a key indicator of both metabolic syndrome and fatty liver disease, often occurring together. Regular testing and lifestyle changes can help identify and manage these interconnected conditions before they progress.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Connection Between Triglycerides, Metabolic Syndrome, and Fatty Liver

When your doctor mentions high triglycerides, it's more than just a number on your lab report. Elevated triglycerides often serve as an early warning sign of deeper metabolic issues, particularly metabolic syndrome and fatty liver disease. These conditions frequently occur together, creating a complex web of health challenges that can significantly impact your long-term wellness.

Triglycerides are a type of fat (lipid) found in your blood. When you eat, your body converts calories it doesn't immediately need into triglycerides, which are stored in fat cells and released between meals for energy. However, when triglyceride levels climb too high, they become a red flag for metabolic dysfunction.

The relationship between high triglycerides, metabolic syndrome, and fatty liver disease is bidirectional and reinforcing. High triglycerides contribute to the development of both conditions, while these conditions, in turn, can further elevate triglyceride levels. Understanding this connection is crucial for early detection and intervention. Regular monitoring of your triglyceride levels alongside other metabolic markers can help you catch these conditions early and take action to protect your health.

Triglyceride Level Classifications and Health Implications

Triglyceride LevelClassificationHealth ImplicationsRecommended Actions
Below 100 mg/dL<100 mg/dLOptimalLow risk for metabolic diseaseMaintain healthy lifestyle
100-149 mg/dL100-149 mg/dLNormalAcceptable but not optimalFocus on prevention through diet and exercise
150-199 mg/dL150-199 mg/dLBorderline HighIncreased risk of metabolic syndrome and fatty liverImplement lifestyle modifications, consider testing for metabolic syndrome
200-499 mg/dL200-499 mg/dLHighSignificant metabolic dysfunction likelyAggressive lifestyle changes, medical evaluation needed
500+ mg/dL≥500 mg/dLVery HighRisk of acute pancreatitisImmediate medical attention required

Triglyceride levels should be measured after a 12-hour fast for accurate results.

What Are Healthy vs. High Triglyceride Levels?

Understanding where your triglyceride levels fall on the spectrum is the first step in assessing your metabolic health. The American Heart Association provides clear guidelines for triglyceride levels, measured in milligrams per deciliter (mg/dL) of blood.

Normal triglyceride levels are below 150 mg/dL, with optimal levels being under 100 mg/dL. Borderline high levels range from 150-199 mg/dL, while high levels fall between 200-499 mg/dL. Very high triglycerides exceed 500 mg/dL and require immediate medical attention due to increased risk of pancreatitis.

It's important to note that triglyceride levels can fluctuate significantly based on recent meals, alcohol consumption, and other factors. For accurate results, triglycerides should be measured after a 12-hour fast. Additionally, levels tend to increase with age and may vary based on gender, with men typically having slightly higher levels than premenopausal women.

High Triglycerides as a Marker for Metabolic Syndrome

Metabolic syndrome is a cluster of conditions that occur together, significantly increasing your risk of heart disease, stroke, and type 2 diabetes. High triglycerides are one of the five key diagnostic criteria for metabolic syndrome. According to the National Cholesterol Education Program, you have metabolic syndrome if you have three or more of the following:

  • Triglycerides of 150 mg/dL or higher
  • Waist circumference greater than 40 inches in men or 35 inches in women
  • HDL cholesterol less than 40 mg/dL in men or 50 mg/dL in women
  • Blood pressure of 130/85 mmHg or higher
  • Fasting glucose of 100 mg/dL or higher

The presence of high triglycerides in metabolic syndrome isn't coincidental. Insulin resistance, the underlying mechanism of metabolic syndrome, directly affects how your body processes and stores fats. When cells become resistant to insulin, the hormone that helps glucose enter cells, several metabolic disruptions occur simultaneously.

In insulin resistance, your liver increases production of very-low-density lipoprotein (VLDL), which carries triglycerides through the bloodstream. Additionally, insulin resistance reduces the activity of lipoprotein lipase, an enzyme that helps clear triglycerides from the blood. This dual effect leads to the accumulation of triglycerides in the bloodstream, making elevated levels a reliable marker for metabolic dysfunction.

The Role of Insulin Resistance

Insulin resistance creates a metabolic environment that promotes triglyceride production and reduces clearance. When insulin signaling is impaired, adipose tissue releases more free fatty acids into the bloodstream. The liver takes up these fatty acids and packages them into triglyceride-rich VLDL particles. Research published in the Journal of Clinical Investigation shows that insulin resistance can increase hepatic VLDL production by up to 3-fold.

Cardiovascular Risk Implications

High triglycerides in the context of metabolic syndrome significantly amplify cardiovascular risk. The combination of elevated triglycerides with low HDL cholesterol creates an atherogenic lipid profile that promotes the development of atherosclerosis. Studies indicate that for every 88 mg/dL increase in triglycerides, cardiovascular risk increases by approximately 14% in men and 37% in women.

Non-alcoholic fatty liver disease (NAFLD) affects approximately 25% of the global population and is strongly associated with elevated triglycerides. The relationship between high triglycerides and fatty liver is so consistent that some researchers consider NAFLD to be the hepatic manifestation of metabolic syndrome.

In fatty liver disease, excess triglycerides accumulate within liver cells, a process called hepatic steatosis. This occurs when the liver's capacity to export triglycerides in VLDL particles is overwhelmed by the influx of fatty acids from the diet, adipose tissue, and increased hepatic synthesis. The result is a buildup of fat within liver cells that can progress from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, and eventually cirrhosis.

Research published in Hepatology found that individuals with triglycerides above 150 mg/dL have a 2.5-fold increased risk of developing NAFLD compared to those with normal levels. Moreover, the severity of fatty liver disease correlates with triglyceride levels, with higher levels indicating more extensive hepatic fat accumulation.

Mechanisms of Triglyceride Accumulation in the Liver

Several mechanisms contribute to triglyceride accumulation in the liver. Increased delivery of free fatty acids from adipose tissue, particularly visceral fat, provides substrate for hepatic triglyceride synthesis. Enhanced de novo lipogenesis, the process by which the liver converts excess carbohydrates into fat, further contributes to triglyceride production. Additionally, impaired fatty acid oxidation and reduced VLDL secretion can trap triglycerides within liver cells.

Identifying Fatty Liver Through Triglyceride Patterns

While imaging studies remain the gold standard for diagnosing fatty liver, certain triglyceride patterns can suggest its presence. A triglyceride-to-HDL ratio greater than 3.5 is associated with increased likelihood of NAFLD. Additionally, the presence of high triglycerides alongside elevated liver enzymes (ALT and AST) strongly suggests hepatic steatosis and warrants further evaluation.

Other Causes of High Triglycerides to Consider

While metabolic syndrome and fatty liver disease are common causes of elevated triglycerides, several other factors can contribute to high levels. Understanding these additional causes helps ensure accurate diagnosis and appropriate treatment.

Genetic factors play a significant role in triglyceride metabolism. Familial hypertriglyceridemia, an inherited condition, can cause severely elevated levels even in the absence of other metabolic abnormalities. Secondary causes include uncontrolled diabetes, hypothyroidism, kidney disease, and certain medications such as beta-blockers, thiazide diuretics, and corticosteroids.

Lifestyle factors significantly impact triglyceride levels. Excessive alcohol consumption can dramatically increase triglycerides, as can a diet high in refined carbohydrates and added sugars. Sedentary behavior, obesity, and smoking also contribute to elevated levels. Additionally, certain medical conditions like pancreatitis, nephrotic syndrome, and HIV can affect triglyceride metabolism.

Testing and Monitoring Your Triglyceride Levels

Regular monitoring of triglycerides is essential for early detection of metabolic dysfunction. A standard lipid panel, which includes triglycerides, total cholesterol, LDL cholesterol, and HDL cholesterol, provides a comprehensive view of your cardiovascular risk profile. For accurate results, fasting for 12 hours before the test is typically required, as triglyceride levels can increase significantly after meals.

Beyond basic triglyceride measurement, advanced testing can provide deeper insights into your metabolic health. Tests for insulin resistance, such as HOMA-IR or fasting insulin levels, can help identify metabolic syndrome in its early stages. Liver function tests, including ALT, AST, and GGT, can suggest the presence of fatty liver disease when elevated alongside high triglycerides. For comprehensive metabolic assessment, consider testing that includes inflammatory markers like high-sensitivity C-reactive protein (hs-CRP) and advanced lipid markers like apolipoprotein B.

The frequency of testing depends on your risk factors and current levels. If your triglycerides are normal and you have no risk factors, testing every 4-6 years may be sufficient. However, if you have elevated levels or risk factors for metabolic syndrome or fatty liver disease, more frequent monitoring every 3-6 months is recommended to track progress and adjust treatment strategies.

Strategies to Lower Triglycerides and Improve Metabolic Health

The good news is that triglyceride levels respond remarkably well to lifestyle modifications. Unlike some cholesterol markers that are largely genetically determined, triglycerides can often be normalized through targeted interventions. The same strategies that lower triglycerides also improve insulin sensitivity and reduce fatty liver, addressing the root causes of metabolic dysfunction.

Dietary Modifications

Diet plays a crucial role in triglyceride management. Reducing intake of refined carbohydrates and added sugars can lower triglycerides by 20-30% within weeks. Focus on whole, unprocessed foods rich in fiber, which slows glucose absorption and improves insulin sensitivity. The Mediterranean diet pattern, emphasizing vegetables, fruits, whole grains, lean proteins, and healthy fats, has been shown to significantly reduce triglycerides and improve fatty liver disease.

Specific dietary strategies include limiting fructose intake, as excessive fructose consumption directly promotes hepatic triglyceride synthesis. Alcohol should be minimized or eliminated, as it can increase triglycerides by up to 50% in susceptible individuals. Increasing omega-3 fatty acid intake through fatty fish or supplementation can reduce triglycerides by 20-50%, with higher doses providing greater benefits for those with very high levels.

Exercise and Physical Activity

Regular physical activity is one of the most effective interventions for lowering triglycerides and improving metabolic health. Aerobic exercise can reduce triglycerides by 15-35%, with benefits seen even with moderate-intensity activity like brisk walking. The American Heart Association recommends at least 150 minutes of moderate-intensity exercise per week, though greater benefits are seen with higher volumes of activity.

Resistance training also plays an important role by increasing muscle mass and improving insulin sensitivity. High-intensity interval training (HIIT) has shown particular promise for improving triglyceride levels and reducing liver fat. Even without weight loss, regular exercise improves triglyceride metabolism and reduces fatty liver, highlighting the importance of physical activity independent of its effects on body weight.

Weight Management and Medical Interventions

For individuals with obesity, weight loss of 5-10% can reduce triglycerides by 20-30% and significantly improve fatty liver disease. Greater weight loss provides proportionally greater benefits, with some studies showing complete resolution of fatty liver with 10% or more weight reduction. However, rapid weight loss should be avoided as it can temporarily worsen liver inflammation.

When lifestyle modifications are insufficient, medical interventions may be necessary. Medications such as fibrates, niacin, and omega-3 fatty acid prescriptions can effectively lower triglycerides. For individuals with diabetes or prediabetes, medications that improve insulin sensitivity, such as metformin or GLP-1 agonists, can address both glucose control and triglyceride levels. Statins, while primarily targeting LDL cholesterol, can also modestly reduce triglycerides and are often prescribed for overall cardiovascular risk reduction.

Taking Action: Your Path to Better Metabolic Health

High triglycerides serve as an important early warning sign of metabolic dysfunction, often indicating the presence of metabolic syndrome, fatty liver disease, or both. Rather than viewing elevated triglycerides as an isolated problem, consider them a window into your overall metabolic health and an opportunity for intervention before more serious complications develop.

The interconnected nature of triglycerides, metabolic syndrome, and fatty liver disease means that addressing one often improves the others. By implementing comprehensive lifestyle changes including dietary modifications, regular physical activity, and weight management, you can significantly improve your triglyceride levels and overall metabolic health. Remember that small, consistent changes often yield the most sustainable results.

Regular monitoring remains crucial for tracking progress and adjusting your approach. Work with your healthcare provider to establish a testing schedule that makes sense for your risk profile and health goals. With proper attention and intervention, high triglycerides can be effectively managed, reducing your risk of progression to more serious metabolic conditions and improving your long-term health outcomes.

References

  1. Grundy, S. M., et al. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology, 73(24), e285-e350.[PubMed][DOI]
  2. Younossi, Z. M., et al. (2016). Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73-84.[PubMed][DOI]
  3. Miller, M., et al. (2011). Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 123(20), 2292-2333.[PubMed][DOI]
  4. Athyros, V. G., et al. (2018). The use of statins alone or in combination with pioglitazone and other drugs for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. Metabolism, 71, 17-32.[PubMed][DOI]
  5. Boden, G. (2011). Obesity, insulin resistance and free fatty acids. Current Opinion in Endocrinology, Diabetes and Obesity, 18(2), 139-143.[PubMed][DOI]
  6. Chalasani, N., et al. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328-357.[PubMed][DOI]

Frequently Asked Questions

How can I test my triglycerides at home?

You can test your triglycerides at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes triglyceride testing along with comprehensive cardiovascular and metabolic markers, providing lab-quality results from the comfort of your home.

What triglyceride level indicates metabolic syndrome?

A triglyceride level of 150 mg/dL or higher is one of the five diagnostic criteria for metabolic syndrome. However, optimal triglyceride levels are below 100 mg/dL, and levels between 100-150 mg/dL may already indicate early metabolic dysfunction.

Can you have high triglycerides without fatty liver disease?

Yes, you can have elevated triglycerides without fatty liver disease. Other causes include genetic conditions, uncontrolled diabetes, hypothyroidism, certain medications, excessive alcohol consumption, or a diet high in refined carbohydrates. However, persistently high triglycerides increase your risk of developing fatty liver over time.

How quickly can lifestyle changes lower triglycerides?

Triglyceride levels can respond rapidly to lifestyle changes. Dietary modifications, particularly reducing refined carbohydrates and added sugars, can lower triglycerides by 20-30% within 2-4 weeks. Regular exercise can produce similar reductions, with some people seeing improvements in as little as one week of consistent activity.

Should I be concerned if only my triglycerides are high?

Yes, isolated high triglycerides warrant attention even if other lipid markers are normal. Elevated triglycerides alone increase cardiovascular risk and often indicate early metabolic dysfunction. They may be the first sign of developing insulin resistance, metabolic syndrome, or fatty liver disease, making early intervention important.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details